• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

噬血细胞性淋巴组织细胞增生症(HLH)的顿挫型:诊断与治疗挑战

Forme Fruste of HLH (haemophagocytic lymphohistiocytosis): diagnostic and therapeutic challenges.

作者信息

Inoue Susumu, Mangat Chetna, Rafe'e Yaseen, Sharman Mahesh

机构信息

Department of Hematology/Oncology, Hurley Children's Hospital, Flint, Michigan, USA.

Department of Pediatrics, Hurley Children's Hospital, Flint, Michigan, USA.

出版信息

BMJ Case Rep. 2015 Jan 29;2015:bcr2014206190. doi: 10.1136/bcr-2014-206190.

DOI:10.1136/bcr-2014-206190
PMID:25634853
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4322283/
Abstract

Infants and young children often present with a persistent febrile episode, sick appearance and negative infectious disease work-up. These patients present serious diagnostic and therapeutic problems to those who provide medical care, particularly since these children are clinically sick. We present a 13 month old child who presented with this clinical challenge. She was ultimately thought to have an incomplete form of HLH with underlying pathophysiology of hypercytokinemia, but also could have been a case of incomplete form of Kawasaki disease. She responded to IVIG, but this does not differentiate one diagnosis from another. Unfortunately we failed to obtain tests to exclude genetic etiologies of HLH, which would be important for predicting severity and risks of future recurrence. We wish to present this case so that one should do a thorough work up to establish a firm diagnosis of HLH and to search for genetic causes of this disorder.

摘要

婴幼儿常常表现为持续性发热、病容以及感染性疾病检查结果为阴性。这些患儿给医护人员带来了严重的诊断和治疗难题,尤其是因为这些孩子临床上病情较重。我们介绍一名面临这一临床挑战的13个月大的儿童。她最终被认为患有不完全型噬血细胞性淋巴组织细胞增生症(HLH),潜在病理生理机制为高细胞因子血症,但也可能是不完全型川崎病的病例。她对静脉注射免疫球蛋白(IVIG)有反应,但这并不能区分这两种诊断。不幸的是,我们未能进行检查以排除HLH的遗传病因,而这对于预测严重程度和未来复发风险很重要。我们希望展示这个病例,以便人们应该进行全面检查以确立HLH的确切诊断,并寻找该疾病的遗传原因。

相似文献

1
Forme Fruste of HLH (haemophagocytic lymphohistiocytosis): diagnostic and therapeutic challenges.噬血细胞性淋巴组织细胞增生症(HLH)的顿挫型:诊断与治疗挑战
BMJ Case Rep. 2015 Jan 29;2015:bcr2014206190. doi: 10.1136/bcr-2014-206190.
2
Hemophagocytic lymphohistiocytosis and Kawasaki disease: combined manifestation and differential diagnosis.噬血细胞性淋巴组织细胞增生症与川崎病:联合表现及鉴别诊断
Pediatr Blood Cancer. 2009 Sep;53(3):493-5. doi: 10.1002/pbc.22098.
3
Kawasaki disease preceding haemophagocytic lymphohistiocytosis: challenges for developing world practitioners.川崎病并发噬血细胞性淋巴组织细胞增生症:对发展中国家从业者的挑战。
Pediatr Blood Cancer. 2010 Jul 1;54(7):1023-5. doi: 10.1002/pbc.22422.
4
A Case of Hemophagocytic Lymphohistiocytosis and Kawasaki Disease: Concurrent or Overlapping Diagnoses?噬血细胞性淋巴组织细胞增生症与川崎病一例:并存还是重叠诊断?
J Pediatr Hematol Oncol. 2018 Jan;40(1):e32-e33. doi: 10.1097/MPH.0000000000000837.
5
Clinical characteristics of hemophagocytic lymphohistiocytosis related to Kawasaki disease.与川崎病相关的噬血细胞性淋巴组织细胞增生症的临床特征
Pediatr Hematol Oncol. 2011 Apr;28(3):230-6. doi: 10.3109/08880018.2010.526685.
6
Macrophage activation syndrome/Hemophagocytic Lymphohistiocytosis and Kawasaki disease.巨噬细胞活化综合征/噬血细胞性淋巴组织细胞增生症与川崎病
Pediatr Blood Cancer. 2010 Sep;55(3):592. doi: 10.1002/pbc.22630.
7
Chemotherapy-sparing treatment of haemophagocytic lymphohistiocytosis with intravenous immunoglobulins and corticosteroids.静脉注射免疫球蛋白和皮质类固醇对噬血细胞性淋巴组织细胞增生症进行的保留化疗治疗。
BMJ Case Rep. 2020 May 5;13(5):e234490. doi: 10.1136/bcr-2020-234490.
8
Haemophagocytic lymphohistiocytosis in a Ghanaian child.一名加纳儿童的噬血细胞性淋巴组织细胞增生症
Ghana Med J. 2012 Dec;46(4):254-7.
9
A child with Epstein-Barr Virus-associated hemophagocytic lymphohistiocytosis complicated by coronary artery lesion mimicking Kawasaki disease.一名患有爱泼斯坦-巴尔病毒相关噬血细胞性淋巴组织细胞增生症并伴有类似川崎病的冠状动脉病变的儿童。
J Pediatr Hematol Oncol. 2013 Oct;35(7):e317-9. doi: 10.1097/MPH.0b013e31828e5281.
10
Hemophagocytic lymphohistiocytosis at initiation of kawasaki disease and their differential diagnosis.川崎病发病初期的噬血细胞性淋巴组织细胞增生症及其鉴别诊断。
Pediatr Hematol Oncol. 2010 Apr;27(3):244-9. doi: 10.3109/08880011003623642.

引用本文的文献

1
Rapid Phenotype-Driven Gene Sequencing with the NeoSeq Panel: A Diagnostic Tool for Critically Ill Newborns with Suspected Genetic Disease.使用NeoSeq Panel进行快速表型驱动的基因测序:一种用于疑似遗传疾病危重新生儿的诊断工具。
J Clin Med. 2020 Jul 23;9(8):2362. doi: 10.3390/jcm9082362.
2
Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases.基因组和外显子组测序以及染色体微阵列在疑似遗传疾病儿童中的诊断及临床应用的荟萃分析。
NPJ Genom Med. 2018 Jul 9;3:16. doi: 10.1038/s41525-018-0053-8. eCollection 2018.
3
Differentiation between incomplete Kawasaki disease and secondary hemophagocytic lymphohistiocytosis following Kawasaki disease using N-terminal pro-brain natriuretic peptide.利用N端前脑钠肽区分不完全川崎病与川崎病继发的噬血细胞性淋巴组织细胞增生症
Korean J Pediatr. 2018 May;61(5):167-173. doi: 10.3345/kjp.2018.61.5.167. Epub 2018 May 28.

本文引用的文献

1
Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children*.阿那白滞素(一种白细胞介素-1受体拮抗剂)在危重症儿童继发性噬血细胞性淋巴组织细胞增生症/脓毒症/多器官功能障碍/巨噬细胞活化综合征治疗中的作用*
Pediatr Crit Care Med. 2014 Jun;15(5):401-8. doi: 10.1097/PCC.0000000000000078.
2
Periodic fever in MVK deficiency: a patient initially diagnosed with incomplete Kawasaki disease.MVK 缺乏症中的周期性发热:一例最初诊断为不完全川崎病的患者。
Pediatrics. 2014 Feb;133(2):e461-5. doi: 10.1542/peds.2012-1372. Epub 2014 Jan 27.
3
Clinical characteristics of hemophagocytic lymphohistiocytosis following Kawasaki disease: differentiation from recurrent Kawasaki disease.川崎病后噬血细胞性淋巴组织细胞增生症的临床特征:与川崎病复发的鉴别
Blood Res. 2013 Dec;48(4):254-7. doi: 10.5045/br.2013.48.4.254. Epub 2013 Dec 24.
4
Hemophagocytic lymphohistiocytosis: pathogenesis and treatment.噬血细胞性淋巴组织细胞增生症:发病机制与治疗
Hematology Am Soc Hematol Educ Program. 2013;2013:605-11. doi: 10.1182/asheducation-2013.1.605.
5
Hemophagocytic lymphohistiocytosis: advances in pathophysiology, diagnosis, and treatment.噬血细胞性淋巴组织细胞增生症:病理生理学、诊断及治疗进展
J Pediatr. 2013 Nov;163(5):1253-9. doi: 10.1016/j.jpeds.2013.06.053. Epub 2013 Aug 15.
6
Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases.儿童自身免疫性疾病相关巨噬细胞活化综合征的临床分析。
Clin Rheumatol. 2012 Aug;31(8):1223-30. doi: 10.1007/s10067-012-1998-0. Epub 2012 May 22.
7
Progress in treatment of ANCA-associated vasculitis.抗中性粒细胞胞质抗体相关性血管炎的治疗进展。
Arthritis Res Ther. 2012 Apr 30;14(2):210. doi: 10.1186/ar3797.
8
Intravenous immunoglobulin treatment for macrophage activation syndrome complicating chronic granulomatous disease.静脉注射免疫球蛋白治疗慢性肉芽肿病合并巨噬细胞活化综合征。
J Clin Immunol. 2012 Apr;32(2):207-11. doi: 10.1007/s10875-011-9616-5. Epub 2011 Nov 26.
9
Clinical characteristics of hemophagocytic lymphohistiocytosis related to Kawasaki disease.与川崎病相关的噬血细胞性淋巴组织细胞增生症的临床特征
Pediatr Hematol Oncol. 2011 Apr;28(3):230-6. doi: 10.3109/08880018.2010.526685.
10
Treatment of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis (EBV-HLH); update 2010.爱泼斯坦-巴尔病毒相关噬血细胞性淋巴组织细胞增生症(EBV-HLH)的治疗;2010年更新
J Pediatr Hematol Oncol. 2011 Jan;33(1):35-9. doi: 10.1097/MPH.0b013e3181f84a52.